Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT : revenue, balance sheet and financial ratios

SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LESPARRE-MEDOC (33340), this company of category PME shows in 2015 a revenue of 2.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT (SIREN 801006842)
Indicator 2025 2024 2023 2022 2021 2020 2017 2015
Revenue N/C N/C N/C N/C N/C N/C N/C 2 445 588 €
Net income 651 749 € 63 018 € 92 180 € 142 099 € 91 426 € 44 855 € 84 187 € 16 655 €
EBITDA N/C N/C N/C N/C N/C N/C N/C 202 432 €
Net margin N/C N/C N/C N/C N/C N/C N/C 0.7%

Revenue and income statement

In 2025, SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT generates positive net income of 652 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2025: 17 k€ -> 652 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

651 749 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

51.015%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

56.645%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

19.8%

Solvency indicators evolution
SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT

Sector positioning

Debt ratio
51.02 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average -25 pts over 3 years

In 2025, the debt ratio of SOCIETE D'EXERCICE LIBERA... (51.02) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
56.65% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good +29 pts over 3 years

In 2025, the financial autonomy of SOCIETE D'EXERCICE LIBERA... (56.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 138.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

138.608

Liquidity indicators evolution
SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT

Sector positioning

Liquidity ratio
138.61 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average

In 2025, the liquidity ratio of SOCIETE D'EXERCICE LIBERA... (138.61) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 300 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1101 days. Excellent situation: suppliers finance 801 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

300 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

1101 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT

Positioning of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT is estimated at 10 353 110 € (range 7 025 669€ - 16 245 455€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
7025k€ 10353k€ 16245k€
10 353 110 € Range: 7 025 669€ - 16 245 455€
NAF 5 année 2025

Valuation method used

Net Income Multiple
651 749 € × 15.9x = 10 353 110 €
Range: 7 025 670€ - 16 245 456€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT

What is the revenue of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT ?

The revenue of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT in 2015 is 2.4 M€.

Is SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT profitable?

Yes, SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT generated a net profit of 652 k€ in 2025.

Where is the headquarters of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT ?

The headquarters of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT is located in LESPARRE-MEDOC (33340), in the department Gironde.

Where to find the tax return of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT ?

The tax return of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT operate?

SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE A ASSOCIE UNIQUE DE PARMACIEN - PHARMACIE LECAT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.